Amylyx Pharmaceuticals
AMLX
Last Price
52 Week Range
$4.47 - $18.61
Next Earnings Date
-
Next Earnings Date
-
Last Price
Amylyx Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Amylyx Pharmaceuticals, Inc. | 10-Q | May 7, 2026 | |
Amylyx Pharmaceuticals, Inc. | 8-K | May 7, 2026 | |
Amylyx Pharmaceuticals, Inc. | DEFA14A | April 23, 2026 | |
Amylyx Pharmaceuticals, Inc. | ARS | April 23, 2026 | |
Amylyx Pharmaceuticals, Inc. | DEF 14A | April 23, 2026 | |
Amylyx Pharmaceuticals, Inc. | 8-K | March 24, 2026 | |
Amylyx Pharmaceuticals, Inc. | 10-K | March 3, 2026 | |
Amylyx Pharmaceuticals, Inc. | 8-K | March 3, 2026 | |
Amylyx Pharmaceuticals, Inc. | S3ASR | March 3, 2026 | |
Amylyx Pharmaceuticals, Inc. | 8-K | January 8, 2026 | |
Amylyx Pharmaceuticals, Inc. | 10-Q | November 6, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | November 6, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | September 10, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | August 27, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | August 7, 2025 | |
Amylyx Pharmaceuticals, Inc. | 10-Q | August 7, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | June 5, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | May 8, 2025 | |
Amylyx Pharmaceuticals, Inc. | 10-Q | May 8, 2025 | |
Amylyx Pharmaceuticals, Inc. | ARS | April 24, 2025 | |
Amylyx Pharmaceuticals, Inc. | DEF 14A | April 24, 2025 | |
Amylyx Pharmaceuticals, Inc. | DEFA14A | April 24, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | March 4, 2025 | |
Amylyx Pharmaceuticals, Inc. | 10-K | March 4, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | January 10, 2025 | |
Amylyx Pharmaceuticals, Inc. | 8-K | December 30, 2024 | |
Amylyx Pharmaceuticals, Inc. | 10-Q | November 7, 2024 | |
Amylyx Pharmaceuticals, Inc. | 8-K | November 7, 2024 | |
Amylyx Pharmaceuticals, Inc. | 8-K | October 17, 2024 | |
Amylyx Pharmaceuticals, Inc. | 8-K | August 8, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.